| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/30/2003 | US20030023036 Drugs, vaccines |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022819 Administering to an animal an angiogenic amount of a hedgehog polypeptide or agonist to promote angiogenesis |
| 01/30/2003 | US20030022367 Cells for use as models in the treatment of heart defects |
| 01/30/2003 | US20030022333 Preservation of samples by dehydration; obtain sample, dry, cool and store on shell |
| 01/30/2003 | US20030022303 Expression vector for use in the treatment of blood disorders |
| 01/30/2003 | US20030022272 Method of inducing an antigen-specific anticytotoxic cell |
| 01/30/2003 | US20030022267 Monitoring the physiological effect of a composition on animal; obtain animal, administer moulator, record physiological adjustments |
| 01/30/2003 | US20030022210 Induction of tissue repair and/or regeneration; obtain cells, incubate with lymphocytes, monitor regeneration of tissues |
| 01/30/2003 | US20030022185 Secreted protein HLHFP03 |
| 01/30/2003 | US20030021851 Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses |
| 01/30/2003 | US20030021798 Use of mCRP to enhance immune responses |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021769 Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 01/30/2003 | US20030021768 Viral mutants that selectively replicate in targeted human cancer cells |
| 01/30/2003 | US20030021767 Recombinant p53 adenovirus methods and compositions |
| 01/30/2003 | US20030021766 Nucleic acid mucosal immunization |
| 01/30/2003 | CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | CA2452556A1 Protein-containing foodstuff comprising a coss-linking enzyme and a hydrocolloid |
| 01/29/2003 | WO2002010350A1 Method of proliferating natural killer cells |
| 01/29/2003 | EP1279728A1 Generation of fully mature and stable dentritic cells from leukapheresis products for clinical applications |
| 01/29/2003 | EP1279408A1 Venting system |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279400A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 01/29/2003 | EP1278878A2 Codon optimisation for expression in retrovirus packaging cells |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 01/29/2003 | EP1278824A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 01/29/2003 | EP1278823A2 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278534A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/29/2003 | EP1278530A2 Chemical modification of mammalian urine and blood |
| 01/29/2003 | EP1278529A2 Therapeutic uses for mesenchymal stromal cells |
| 01/29/2003 | EP1002110B1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 01/29/2003 | EP0912188B1 Selective adsorbent for binding retroviruses |
| 01/29/2003 | EP0863776B1 A biologic material comprising an efficient culture of bone marrow stem cells partially or completely differentiated into connective tissue cells and a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid derivative |
| 01/29/2003 | EP0841942B1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 01/29/2003 | CN1393546A Industrial fermenting process of sphaeroid red bacteria and its fermented liquid |
| 01/29/2003 | CN1393247A Chinese-medicinal ointment for treating burn and scald |
| 01/29/2003 | CN1393245A Plaster for treating lumbar intervertebral disk protrusion |
| 01/29/2003 | CN1393242A Plaster for treating mastoplasia |
| 01/29/2003 | CN1393235A Plaster for treating facial neuritis and its preparing process |
| 01/29/2003 | CN1393231A Antisanility health-care cream and its preparing process |
| 01/29/2003 | CN1393225A Process for preparing melissa powder extract |
| 01/29/2003 | CN1099889C Enema liquor for woman pelvic inflammation |
| 01/29/2003 | CN1099887C Medicated liquor for curing rheumatism |
| 01/29/2003 | CN1099886C Medicine for nasopharyngeal cancer and its preparing process |
| 01/29/2003 | CN1099885C Instant granule for strengthening stomach and eliminating indigestion |
| 01/29/2003 | CN1099884C Chinese patent medicine for treating nephrosis |
| 01/29/2003 | CN1099883C Tibeten medicine for treating hepatitis B and its preparing process |
| 01/29/2003 | CN1099881C Chinese medicine pill for treating male infertility |
| 01/29/2003 | CN1099878C Application of red koji and its ethyl acetate extract in preparing medicine or health-care food |
| 01/29/2003 | CN1099876C Medicine for curing psoriasis |
| 01/29/2003 | CN1099875C Dermatosis treating medicine |
| 01/29/2003 | CN1099873C Application of Yanglazi in medicine for treating osteoarthropathy |
| 01/29/2003 | CN1099872C Application of lung surface active matter to pharmaceutical industry |
| 01/29/2003 | CA2417579A1 Method of proliferating natural killer cells |
| 01/28/2003 | US6511848 Propagating preferential blood cells; obtain blood cells, incubate with interleukins, culture, harvest blood cells |
| 01/28/2003 | US6511847 Recombinant adenovirus using liposome-mediated cotransfection and the direct observation of a cytopathic effect in the transfected cells; tumor suppressor gene |
| 01/28/2003 | US6511807 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 01/28/2003 | US6511685 Heating in presence of bacteria then yeast; adding calcium, magnesium and/or potassium components; filtering and drying |
| 01/28/2003 | US6511661 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 01/28/2003 | US6511473 Implantable bioartificial active secretion system |
| 01/26/2003 | CA2353804A1 Control of myogenesis by modulation of wnt activity |
| 01/23/2003 | WO2003006950A2 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 01/23/2003 | WO2003006691A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 01/23/2003 | WO2003006662A1 Anti-neoplastic viral agents |
| 01/23/2003 | WO2003006641A2 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 01/23/2003 | WO2003006639A1 Cell and transgenic animal modelling human antigenic presentation and their uses |
| 01/23/2003 | WO2003006638A1 Liver cell progenitor and use for treatment of live diseases |
| 01/23/2003 | WO2003006616A2 Pseudotyped adeno-associated viruses and uses thereof |
| 01/23/2003 | WO2003006613A2 Methods for ex vivo propagation of somatic stem cells |
| 01/23/2003 | WO2003006612A2 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | WO2003006607A2 Inhibition of apoptosis process and improvement of cell performance |
| 01/23/2003 | WO2003006500A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 01/23/2003 | WO2003006477A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 01/23/2003 | WO2003006057A1 Composition and method for the treatment of disease |
| 01/23/2003 | WO2003006035A1 Anti-emetic compositions comprising mycobacterial material |
| 01/23/2003 | WO2003006034A2 Herbal formulation |
| 01/23/2003 | WO2003006033A2 Herbal formulation |
| 01/23/2003 | WO2003005978A1 Remedy against skin diseases |
| 01/23/2003 | WO2003005964A2 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | WO2003005837A1 Enteral formulations |
| 01/23/2003 | WO2002076475A3 Glycosaminoglycan anticoagulants derived from fish |
| 01/23/2003 | WO2002061424A3 Organ system microarrays |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002047731A3 Drug delivery compositions and coated medical devices |
| 01/23/2003 | WO2002018585A3 Packaging of positive-strand rna virus replicon particles |
| 01/23/2003 | WO2002016553A3 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 01/23/2003 | WO2001089548A3 Pharmaceutical use of fibulin-1 |
| 01/23/2003 | US20030018357 Wound closure system and methods |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030018004 Vector |
| 01/23/2003 | US20030017973 Fraction extracted from archaebacteria for cosmetic purposes |
| 01/23/2003 | US20030017969 Methods and pharmaceutical compositions for healing wounds |
| 01/23/2003 | US20030017589 Culturing preferential cells; generate nutrient broth, inoculate with cells, propagate cells, recover cells |